As of Sep 30
| +1.09 / +2.18%|
The 19 analysts offering 12-month price forecasts for CSPC Pharmaceutical Group Ltd have a median target of 54.80, with a high estimate of 61.24 and a low estimate of 51.56. The median estimate represents a +7.07% increase from the last price of 51.18.
The current consensus among 19 polled investment analysts is to Buy stock in CSPC Pharmaceutical Group Ltd. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.